Association between maternal serum analytes and third trimester fetal growth restriction
Authors:
- 1 January 2026
- journal article
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 77 (6)
Abstract
Article: Association between maternal serum analytes and third trimester fetal growth restriction - Minerva Obstetrics and Gynecology 2025 Jun 30 - Minerva Medica - JournalsKeywords
This publication has 24 references indexed in Scilit:
- Screening for fetal growth restriction and placental insufficiencySeminars in Fetal and Neonatal Medicine, 2018
- Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort studyThe Lancet, 2015
- Population-based biomarker screening and the development of severe preeclampsia in CaliforniaAmerican Journal of Obstetrics and Gynecology, 2014
- Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimesterPrenatal Diagnosis, 2014
- Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunctionPrenatal Diagnosis, 2014
- First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restrictionPlacenta, 2011
- Adverse Pregnancy Outcomes After Abnormal First-Trimester Screening for AneuploidyClinics In Laboratory Medicine, 2010
- Maternal Nativity Status and Birth Outcomes in Asian ImmigrantsJournal of Immigrant and Minority Health, 2008
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2004